Skip to main content
. 2020 Nov 12;10:548300. doi: 10.3389/fonc.2020.548300

Figure 4.

Figure 4

Metabolic pathways significantly disturbed by anlotinib treatment. The blue arrows indicated a significant (P < 0.05) upregulation of metabolite concentrations in plasma after treatment with anlotinib.